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INTRODUCTION
Patellar tendinopathy is very common among elite and
recreational athletes who participate in sports that involve
jumping and quick directional changes. Several different
therapies and modalities have been experimented with to
increase the healing of the tendon. The purpose of this case
study and review is to evaluate the effectiveness of plateletrich plasma injection therapy on treating refractory longterm patellar tendinopathy.
The administration of platelet-rich plasma (PRP) is a new
and clinically successful approach in the management of
tendinosis and/or tendinopathy. PRP is an autologous
blood derivative that contains a higher concentration of
platelets with respect to baseline blood level. The biological
rationale is that the platelets are a source of several growth
factors amongst several other bioactive molecules that play
an important role in tissue homeostasis and the healing
cascade. The application of PRP into a damaged tendon
could therefore encourage tissue regeneration. PRP has
been applied in several clinical conditions, both as a
conservative injective approach or to augment surgical
procedures.
METHODS
A full history was taken from the case study subject and
a thorough evaluation was performed. The patient began
physical therapy 3 weeks post-injection and continued
through a progressive 5 week physical therapy program
beginning with proprioception and stretching exercises and
progressing into plyometrics and sport-specific training.
An extensive and comprehensive evidence-based literature
search was conducted looking in 4 different databases,
including PubMed, CINAHL Plus, Cochrane, and Web
of Knowledge. A total of 20 articles were collected, and of
those, 8 were selected for extensive analytical review.
FINDINGS
Case study subject regained full functional strength and
range of motion and a complete relief of knee pain at
completion of physical therapy, 8 weeks post-injection.
There was limited research on this topic, and even less
published research that is considered high quality evidence.
Much of the published research have high clinical and
statistical relevance, but the sample sizes are smaller and
lack randomization, blinding, and a control group. Plateletrich plasma (PRP) injection looks to be a promising
treatment for patellar tendinopathy from a standpoint of
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clinical relevance. This type of modality looks to provide
another treatment option for those with unrelenting,
reoccurring, or recalcitrant tendinopathy.
CONCLUSION
Physical therapy is often a very successful tool in the
treatment of patellar tendinopathy and should be followed
and implemented for at least 3 to 6 months as a first
line of treatment. For those individuals suffering from
recalcitrant patellar tendinopathy that have failed more
conservative treatments, it may be worthwhile to include
PRP injection therapy as a recommendation. Studies have
shown decreases in tendon irregularities and results of pain
reduction and/or increased function after PRP injection.
Although current research is of lower quality and confers
no clear benefit that can be stated with certainty, we can
say PRP injection is a very safe and minimally invasive
procedure that almost always provided patients with some
sort of pain reduction and allowed many of the subjects
to return to sport and play to full capacity. Further high
quality research is needed in this area.

